Piddock L J, Hall M C, Wise R
Department of Medical Microbiology, University of Birmingham Medical School, United Kingdom.
Antimicrob Agents Chemother. 1990 Jun;34(6):1088-93. doi: 10.1128/AAC.34.6.1088.
The inhibition of supercoiling activity of reconstituted Escherichia coli DNA gyrase by lomefloxacin, ciprofloxacin, and norfloxacin was determined. The concentrations of quinolones needed to inhibit DNA synthesis in Escherichia coli, Enterobacter cloacae, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were also measured. The kinetics of uptake of [14C]lomefloxacin and unlabeled lomefloxacin into whole cells of E. coli KL-16 and S. aureus NCTC 8532 and the induction of RecA in E. coli GC2241 were assayed. All strains had wild-type susceptibilities to quinolones. The concentration of quinolones needed to inhibit DNA synthesis by 50% correlated with the MIC for members of the family Enterobacteriaceae and P. aeruginosa. The concentration of quinolones needed to inhibit DNA synthesis by 50% for late-logarithmic-phase S. aureus also correlated with the MIC, unlike the data from early-logarithmic-phase cultures. E. coli and S. aureus showed a similar pattern of uptake kinetics of [14C]lomefloxacin and unlabeled lomefloxacin, indicating that the difference in the susceptibilities of the two species is probably due to different target site affinities. Essentially, lomefloxacin was less active than ciprofloxacin and ofloxacin and had activity similar to those of norfloxacin and enoxacin.
测定了洛美沙星、环丙沙星和诺氟沙星对重组大肠杆菌DNA回旋酶超螺旋活性的抑制作用。还测定了喹诺酮类药物抑制大肠杆菌、阴沟肠杆菌、粘质沙雷氏菌、肺炎克雷伯菌、铜绿假单胞菌和金黄色葡萄球菌中DNA合成所需的浓度。检测了[14C]洛美沙星和未标记的洛美沙星进入大肠杆菌KL-16和金黄色葡萄球菌NCTC 8532全细胞的摄取动力学以及大肠杆菌GC2241中RecA的诱导情况。所有菌株对喹诺酮类药物均具有野生型敏感性。抑制DNA合成50%所需的喹诺酮类药物浓度与肠杆菌科成员和铜绿假单胞菌的最低抑菌浓度(MIC)相关。与对数早期培养的数据不同,对数后期金黄色葡萄球菌抑制DNA合成50%所需的喹诺酮类药物浓度也与MIC相关。大肠杆菌和金黄色葡萄球菌对[14C]洛美沙星和未标记的洛美沙星表现出相似的摄取动力学模式,表明这两个物种敏感性的差异可能是由于靶位点亲和力不同。从本质上讲,洛美沙星的活性低于环丙沙星和氧氟沙星,其活性与诺氟沙星和依诺沙星相似。